Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG

NCT00004084 is registered in ClinicalTrials.gov with Garden State Cancer Center at the Center for Molecular Medicine and Immunology as lead sponsor.

NCT NCT00004084
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00004084 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase I/II Radioimmunotherapy of Non-Hodgkin's Lymphoma With Radiolabeled Humanized Immu-LL2: Treatment With 90Y-hLL2 IgG
Lead sponsor
Garden State Cancer Center at the Center for Molecular Medicine and Immunology
Phase
Phase 1/2
Overall status
Completed
Start date
April 30, 1998
Completion date
Not reported
Enrollment
21 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

leukemia, lymphoma